• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型噻吩并[2,3-b]嘧啶类衍生物的设计与合成及其作为酪氨酸激酶抑制剂的细胞毒性生物评价及其诱导细胞凋亡和自噬作用。

Design and Synthesis of New Thiophene/Thieno[2,3-]pyrimidines along with Their Cytotoxic Biological Evaluation as Tyrosine Kinase Inhibitors in Addition to Their Apoptotic and Autophagic Induction.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh P.O. Box 84428, Saudi Arabia.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University, Ain Helwan, Cairo P.O. Box 11795, Egypt.

出版信息

Molecules. 2021 Dec 26;27(1):123. doi: 10.3390/molecules27010123.

DOI:10.3390/molecules27010123
PMID:35011354
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8746632/
Abstract

This work describes the synthesis and anticancer activity against kinase enzymes of newly designed thiophene and thieno[2,3-]pyrimidine derivatives, along with their potential to activate autophagic and apoptotic cell death in cancer cells. The designed compounds were scanned for their affinity for kinases. The results were promising with affinity ranges from 46.7% to 13.3%. Molecular docking studies were performed, and the compounds were then screened for their antiproliferative effects. Interestingly, compounds and resulted in higher cytotoxic effects than the reference standard against MCF-7 and HepG-2. The compounds were evaluated for their induction of apoptosis and/or necrosis on HT-29 and HepG-2. Three compounds induced significant early apoptosis compared to untreated control HT-29 cells, and four derivatives were more significant compared to untreated HepG-2 cells. We further investigated the effect of four compounds on the autophagy process within HT-29, HepG-2, and MCF-7 cells with flow cytometry. Similar to the apoptosis results, compound showed the highest autophagic induction among all compounds. The potential inhibitory activity of the synthesized compounds on kinases was assessed. Screened compounds showed inhibition activity ranging from 41.4% to 83.5%. Compounds recorded significant inhibition were further investigated for their specific FLT3 kinase inhibitory activity. Noticeably, Compound exhibited the highest inhibitory activity against FLT3.

摘要

这项工作描述了新设计的噻吩和噻吩并[2,3-d]嘧啶衍生物的合成及其对激酶酶的抗癌活性,以及它们在癌细胞中激活自噬和凋亡细胞死亡的潜力。设计的化合物被扫描其对激酶的亲和力。结果令人鼓舞,亲和力范围从 46.7%到 13.3%。进行了分子对接研究,然后筛选化合物的抗增殖作用。有趣的是,化合物 和 对 MCF-7 和 HepG-2 的细胞毒性作用高于参考标准。评估了这些化合物对 HT-29 和 HepG-2 细胞诱导凋亡和/或坏死的作用。与未经处理的对照 HT-29 细胞相比,三种化合物诱导了明显的早期凋亡,与未经处理的 HepG-2 细胞相比,四种衍生物更为显著。我们进一步用流式细胞术研究了四种化合物对 HT-29、HepG-2 和 MCF-7 细胞自噬过程的影响。与凋亡结果相似,化合物 在所有化合物中表现出最高的自噬诱导作用。评估了合成化合物对激酶的潜在抑制活性。筛选出的化合物表现出 41.4%至 83.5%的抑制活性。对记录到显著抑制作用的化合物进行了进一步研究,以确定其对特定的 FLT3 激酶的抑制活性。值得注意的是,化合物 对 FLT3 表现出最高的抑制活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/89630aecad54/molecules-27-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/4170424ceb1c/molecules-27-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/4a69f2f73e66/molecules-27-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/0b4355b80305/molecules-27-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/751af3a43fbc/molecules-27-00123-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/88ecd4197c3f/molecules-27-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/6e0c927d17fd/molecules-27-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/1bd2f193f35a/molecules-27-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/89630aecad54/molecules-27-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/4170424ceb1c/molecules-27-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/4a69f2f73e66/molecules-27-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/0b4355b80305/molecules-27-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/751af3a43fbc/molecules-27-00123-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/88ecd4197c3f/molecules-27-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/6e0c927d17fd/molecules-27-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/1bd2f193f35a/molecules-27-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed76/8746632/89630aecad54/molecules-27-00123-g007.jpg

相似文献

1
Design and Synthesis of New Thiophene/Thieno[2,3-]pyrimidines along with Their Cytotoxic Biological Evaluation as Tyrosine Kinase Inhibitors in Addition to Their Apoptotic and Autophagic Induction.新型噻吩并[2,3-b]嘧啶类衍生物的设计与合成及其作为酪氨酸激酶抑制剂的细胞毒性生物评价及其诱导细胞凋亡和自噬作用。
Molecules. 2021 Dec 26;27(1):123. doi: 10.3390/molecules27010123.
2
Design, synthesis and cytotoxic evaluation of new thieno[2,3-d]pyrimidine analogues as VEGFR-2/AKT dual inhibitors, apoptosis and autophagy inducers.新型噻吩并[2,3-d]嘧啶类似物的设计、合成及作为 VEGFR-2/AKT 双重抑制剂、诱导细胞凋亡和自噬的细胞毒性评价。
Bioorg Chem. 2024 Sep;150:107622. doi: 10.1016/j.bioorg.2024.107622. Epub 2024 Jul 9.
3
New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.新型噻吩并[3,2-d]嘧啶衍生物的设计、合成与生物评价:作为抗增殖剂、EGFR 和 ARO 抑制剂诱导乳腺癌细胞凋亡。
Bioorg Chem. 2021 Oct;115:105208. doi: 10.1016/j.bioorg.2021.105208. Epub 2021 Jul 26.
4
Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.新型吡唑并[3,4-d]嘧啶衍生物骨架作为有效 EGFR 抑制剂和细胞凋亡诱导剂的设计、合成、生物评价和分子对接研究。
Bioorg Chem. 2021 Nov;116:105325. doi: 10.1016/j.bioorg.2021.105325. Epub 2021 Sep 4.
5
Design, synthesis and anticancer evaluation of thieno[2,3-d]pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers.设计、合成并评估噻吩并[2,3-d]嘧啶衍生物作为双重 EGFR/HER2 抑制剂和凋亡诱导剂的抗癌活性。
Bioorg Chem. 2019 Jul;88:102944. doi: 10.1016/j.bioorg.2019.102944. Epub 2019 Apr 25.
6
Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives.一些新噻吩和噻吩[2,3-d]嘧啶衍生物的合成及体外抗肿瘤活性评价。
Bioorg Chem. 2018 Dec;81:587-598. doi: 10.1016/j.bioorg.2018.09.022. Epub 2018 Sep 13.
7
Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights.新型咪唑啉酮衍生物作为有潜力的细胞周期检测点激酶 1 和 2 的双重抑制剂:设计、合成、细胞毒性评估和作用机制研究。
Bioorg Chem. 2024 Aug;149:107471. doi: 10.1016/j.bioorg.2024.107471. Epub 2024 May 19.
8
Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.新型吡唑并[3,4-d]嘧啶类化合物作为潜在的细胞毒剂:设计、合成、分子对接和 CDK2 抑制。
Anticancer Agents Med Chem. 2019;19(11):1368-1381. doi: 10.2174/1871520619666190417153350.
9
Novel Tetrahydrobenzo [b] Thiophene Compounds Exhibit Anticancer Activity through Enhancing Apoptosis and Inhibiting Tyrosine Kinase.新型四氢苯并[b]噻吩化合物通过增强细胞凋亡和抑制酪氨酸激酶表现出抗癌活性。
Anticancer Agents Med Chem. 2018;18(12):1761-1769. doi: 10.2174/1871520618666180813120558.
10
Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.新型3,6-二甲基-1-苯基-4-(取代甲氧基)吡唑并[3,4-d]嘧啶衍生物的合成、表皮生长因子受体抑制作用及抗癌活性
Anticancer Agents Med Chem. 2017;17(10):1389-1400. doi: 10.2174/1872211311666170213105004.

引用本文的文献

1
Antimicrobial Evaluation of Sulfonamides after Coupling with Thienopyrimidine Coplanar Structure.噻吩并嘧啶共面结构偶联后磺胺类药物的抗菌活性评价
Pharmaceuticals (Basel). 2024 Jan 31;17(2):188. doi: 10.3390/ph17020188.
2
2-Alkyl-Substituted-4-Amino-Thieno[2,3-]Pyrimidines: Anti-Proliferative Properties to In Vitro Breast Cancer Models.2- 烷基取代-4-氨基噻吩并[2,3-d]嘧啶类化合物:体外乳腺癌模型的抗增殖活性。
Molecules. 2023 Aug 30;28(17):6347. doi: 10.3390/molecules28176347.
3
In Silico Screening and Anticancer-Apoptotic Evaluation of Newly Synthesized Thienopyrimidine/Sulfonamide Hybrids.

本文引用的文献

1
New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.新型含 C2 和 N3 取代基的噻吩并[2,3-d]嘧啶类化合物具有纳摩尔级别的细胞毒性。
Anticancer Agents Med Chem. 2022;22(6):1201-1212. doi: 10.2174/1871520621666210727130227.
2
Design, synthesis and biological evaluation of a new thieno[2,3-]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines.新型噻吩并[2,3-d]嘧啶基脲衍生物的设计、合成及抗肿瘤活性评价——对他莫昔芬敏感和耐药乳腺癌细胞系的潜在作用。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1641-1656. doi: 10.1080/14756366.2020.1804383.
3
新型噻吩嘧啶/磺胺类杂合化合物的计算机筛选及抗癌-凋亡评价。
Int J Mol Sci. 2023 Jun 29;24(13):10827. doi: 10.3390/ijms241310827.
4
Design and cytotoxic evaluation via apoptotic and antiproliferative activity for novel 11(4-aminophenylamino)neocryptolepine on hepatocellular and colorectal cancer cells.新型 11(4-氨基苯氨基)新隐卡品对肝癌和结直肠癌细胞的设计及细胞毒性评价:凋亡和抗增殖活性。
Apoptosis. 2023 Apr;28(3-4):653-668. doi: 10.1007/s10495-023-01810-y. Epub 2023 Jan 31.
5
Design, Synthesis, and Antiproliferative Activity of Novel Neocryptolepine-Rhodanine Hybrids.新型新隐丹参酮-缩氨基硫脲杂合体的设计、合成及抗增殖活性。
Molecules. 2022 Nov 5;27(21):7599. doi: 10.3390/molecules27217599.
6
Synthesis, Biocidal and Antibiofilm Activities of New Isatin-Quinoline Conjugates against Multidrug-Resistant Bacterial Pathogens along with Their In Silico Screening.新型异吲哚酮-喹啉缀合物对多重耐药细菌病原体的合成、杀菌和抗生物膜活性及其计算机模拟筛选
Antibiotics (Basel). 2022 Oct 28;11(11):1507. doi: 10.3390/antibiotics11111507.
7
In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation.针对Fms相关受体酪氨酸激酶-3的新型合成噻吩并嘧啶的计算机模拟筛选及其体外生物学评价
Pharmaceuticals (Basel). 2022 Jan 29;15(2):170. doi: 10.3390/ph15020170.
Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation.
基于乙基 2-氨基-4,5,6,7-四氢苯并噻吩-3-羧酸酯的新型乳腺癌凋亡诱导剂的发现:合成、体外和体内活性评价。
Molecules. 2020 May 28;25(11):2523. doi: 10.3390/molecules25112523.
4
Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin.各种酪氨酸激酶抑制剂的自噬诱导能力比较以及它们在与阿奇霉素联合治疗时通过抑制癌细胞自噬增强细胞毒性的研究。
Biochem Biophys Rep. 2020 Mar 17;22:100750. doi: 10.1016/j.bbrep.2020.100750. eCollection 2020 Jul.
5
Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation.发现一种高选择性的 FLT3 抑制剂,对携带 FLT3-ITD 突变的 AML 细胞具有特异性增殖抑制作用。
Eur J Med Chem. 2019 Feb 1;163:195-206. doi: 10.1016/j.ejmech.2018.11.063. Epub 2018 Nov 27.
6
Kinase-targeted cancer therapies: progress, challenges and future directions.激酶靶向癌症疗法:进展、挑战与未来方向。
Mol Cancer. 2018 Feb 19;17(1):48. doi: 10.1186/s12943-018-0804-2.
7
Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity.新型噻吩并[2,3-d]嘧啶衍生物的合成及其细胞毒性和 EGFR 抑制活性评价。
Anticancer Agents Med Chem. 2018;18(5):747-756. doi: 10.2174/1871520618666180124121441.
8
Medicinal Attributes of Thienopyrimidine Based Scaffold Targeting Tyrosine Kinases and Their Potential Anticancer Activities.基于噻吩嘧啶骨架靶向酪氨酸激酶的药用特性及其潜在的抗癌活性。
Arch Pharm (Weinheim). 2017 Nov;350(11). doi: 10.1002/ardp.201700242. Epub 2017 Oct 13.
9
Ratiometric analysis of Acridine Orange staining in the study of acidic organelles and autophagy.吖啶橙染色在酸性细胞器和自噬研究中的比率分析
J Cell Sci. 2016 Dec 15;129(24):4622-4632. doi: 10.1242/jcs.195057. Epub 2016 Nov 14.
10
Synthesis, anticancer activity and photostability of novel 3-ethyl-2-mercapto-thieno[2,3-d]pyrimidin-4(3H)-ones.新型3-乙基-2-巯基噻吩并[2,3-d]嘧啶-4(3H)-酮的合成、抗癌活性及光稳定性
Eur J Med Chem. 2016 Nov 10;123:69-79. doi: 10.1016/j.ejmech.2016.07.022. Epub 2016 Jul 14.